Lumida
/LMAT
⌘K
LeMaitre Vascular Inc

LeMaitre Vascular Inc

LMAT
$80.59USD+2.27%+1.79 today

MARKET CAP

1.8B

P/E (TTM)

29.7x

FWD P/E

DAY RANGE

$79 – $81

52W RANGE

$78
$118

AI Summary

Stalk
StalkMedium

LMAT is in a Stage 3 base with a Post-Capitulation pattern and oversold context suggesting a medium-term mean-reversion bounce. However, price trades below the short EMAs and lacks clear upward momentum, so execution is deferred. Stalk for a reclaim and acceptance above the 9-EMA and 20-EMA within the consolidation zone near recent lows before committing.

  • 10% organic sales growth in Q2 2026 driven by price hikes and unit sales
  • Artograph revenue projected to rise from $4M in 2025 to $11M in 2026
  • Q2 EPS $0.74 missed analyst $0.81 estimate amid export headwinds
Full analysis →

Buying

5

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY3.27 M314.07 M+128.82 K-8.5%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY169.50 K16.27 M+31.00 K+7.6%0.02%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL107.23 K10.29 M+-19.88 K-25.9%0.02%
JC

Jpmorgan Chase & Co

Q2 2026

SELL68.95 K6.71 M+-39.24 K-41.9%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL48.83 K4.69 M+-54.55 K-58.5%0.00%
MG

Man Group Plc

Q2 2026

BUY29.42 K2.82 M+1.03 K-8.9%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY21.66 K2.37 M+13.25 K+247.2%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY20.62 K1.98 M+221.00-11.2%0.00%
MM

Millennium Management LLC

Q2 2026

SELL8.99 K863.06 K+-45.01 K-85.4%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL0.000.00+-22.79 K-100.0%0.00%